Description
A somatostatin receptor agonist (Kis = 875, 0.57, 26.8, >1,000, and 6.8 nM for SST1-5 receptors, respectively); selectively binds to SST2 over SST3 and SST5 receptors (IC50s = 0.02, 92.9, and 21.8 nM, respectively); inhibits the secretion of growth hormone in vitro in rat pituitary cells three-fold more potently than somatostatin; inhibits the secretion of growth hormone in vivo in rhesus monkey (ID50 = 0.38 µg/kg per hour); inhibits proliferation of VEGF-stimulated human umbilical endothelial cells (HUVECs) with an EC50 value of approximately 1 µM; inhibits growth of LCI-D20 human hepatocellular carcinoma cell tumors in a nude mouse xenograft model when administered at a dose of 50 µg/kg twice daily
Formal name: D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-cyclic(2→7)-disulfide, L-cysteinamide, monoacetate
Synonyms: SMS 201-995
Molecular weight: 1,079.30
CAS: 760176-26-9
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Hormones & Receptors||Research Area|Neuroscience|Neuroendocrinology